Sign in

CIK 0001055726

  • Non-accelerated filer
  • Smaller reporting company

INOVIO PHARMACEUTICALS, INC.

Sign in to watch
Ticker
INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330969592
Phone
+1 858-410-3134
Business address
660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
Former names
INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-03-05 Bagarazzi Mark Chief Medical Officer Exercise or conversion +27,567 109,080
2019-03-05 Bagarazzi Mark Chief Medical Officer Shares withheld for taxes −8,408 $3.61 $30K 100,672
2019-03-05 Bagarazzi Mark Chief Medical Officer Exercise or conversion · Restricted Stock Unit −27,567 55,133
2018-03-10 Bagarazzi Mark Chief Medical Officer Exercise or conversion +20,434 87,166
2018-03-10 Bagarazzi Mark Chief Medical Officer Shares withheld for taxes −5,653 $4.51 $25K 81,513
2018-03-10 Bagarazzi Mark Chief Medical Officer Exercise or conversion · Restricted Stock Unit −20,434 40,866
2018-03-09 Bagarazzi Mark Chief Medical Officer Exercise or conversion +25,000 73,628
2018-03-09 Bagarazzi Mark Chief Medical Officer Shares withheld for taxes −6,896 $4.51 $31K 66,732
2018-03-09 Bagarazzi Mark Chief Medical Officer Exercise or conversion · Restricted Stock Unit −25,000 25,000
2018-03-05 Bagarazzi Mark Chief Medical Officer Exercise or conversion +8,333 51,443
2018-03-05 Bagarazzi Mark Chief Medical Officer Shares withheld for taxes −2,815 $4.29 $12K 48,628
2018-03-05 Bagarazzi Mark Chief Medical Officer Exercise or conversion · Restricted Stock Unit −8,333 0
2018-03-05 Bagarazzi Mark Chief Medical Officer Grant or award · Common Stock Option +126,500 126,500
2018-03-05 Bagarazzi Mark Chief Medical Officer Grant or award · Restricted Stock Unit +82,700 82,700
2017-03-10 Bagarazzi Mark Chief Medical Officer Grant or award · Common Stock Options +100,000 $6.68 $668K 100,000
2017-03-10 Bagarazzi Mark Chief Medical Officer Grant or award · Restricted Stock Unit +61,300 61,300
2017-03-09 Bagarazzi Mark Chief Medical Officer Exercise or conversion +25,000 50,758
2017-03-09 Bagarazzi Mark Chief Medical Officer Shares withheld for taxes −7,648 $6.61 $51K 43,110
2017-03-09 Bagarazzi Mark Chief Medical Officer Exercise or conversion · Restricted Stock Unit −25,000 50,000
2017-03-06 Bagarazzi Mark Chief Medical Officer Shares withheld for taxes −3,067 $6.95 $21K 25,758

Page 1 of 2 · 22 trades